Yangshin Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yangshin Park has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Quyen Q. Hoang
Indiana University School of Medicine
2 shared publications Agnita Boon
Erasmus MC, University Medical Center, Department of Neurology, Rotterdam, The Netherlands
1 shared publication- Anneke J.A. Kievit
Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam
1 shared publication - Cardea W Hoang
Department of Biochemistry, Molecular Biology, and Pharmacology, Indiana University School of Medicine , Indianapolis, IN 46202, USA
1 shared publication - Christina Fevga
Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, the Netherlands
1 shared publication Chunxiang Wu
Department of Biochemistry, Molecular Biology, and Pharmacology, Indiana University School of Medicine , Indianapolis, IN 46202, USA
1 shared publication
Latest Publications
- Open Access
- 7 April 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (4)
Structural and biochemical basis of ROC-dependent activation of LRRK2
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease, yet the molecular mechanism governing LRRK2 activation remains incompletely understood. LRRK2 is a large multidomain enzyme whose kinase activity is regulated by intramolecular interactions and by its Ras of complex proteins (ROC) GTPase domain. Here, we combine cryo–electron microscopy, X-ray crystallography, and structure-guided biochemical perturbations to define how ROC conformational switching regulates LRRK2 activation. Cryo-EM reconstructions reveal that monomeric full-length LRRK2 samples three distinct conformational states—autoinhibited, intermediate, and activated—indicating that large-scale activation-associated rearrangements can occur through an intrinsic intramolecular pathway, independently of Rab29 binding, higher-order oligomerization, or membrane association. A 1.6-Å crystal structure of an extended ROC construct reveals intrinsic conformational plasticity within the GTPase switch regions that likely underlies these transitions. Structure-guided disulfide engineering identifies a functional coupling between residue R1441 and switch II that directly modulates GTPase activity in both isolated ROC and full-length LRRK2. Disruption of this coupling phenocopies the disease-associated R1441H mutation. Together, these findings establish ROC as a dynamic conformational engine that drives a multistep intramolecular activation mechanism in LRRK2, providing mechanistic insight into how pathogenic mutations promote aberrant kinase activation.
- 7 April 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (4)
Open AccessStructural and biochemical basis of ROC-dependent activation of LRRK2
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease, yet the molecular mechanism governing LRRK2 activation remains incompletely understood. LRRK2 is a large multidomain enzyme whose kinase activity is regulated by intramolecular interactions and by its Ras of complex proteins (ROC) GTPase domain. Here, we combine cryo–electron microscopy, X-ray crystallography, and structure-guided biochemical perturbations to define how ROC conformational switching regulates LRRK2 activation. Cryo-EM reconstructions reveal that monomeric full-length LRRK2 samples three distinct conformational states—autoinhibited, intermediate, and activated—indicating that large-scale activation-associated rearrangements can occur through an intrinsic intramolecular pathway, independently of Rab29 binding, higher-order oligomerization, or membrane association. A 1.6-Å crystal structure of an extended ROC construct reveals intrinsic conformational plasticity within the GTPase switch regions that likely underlies these transitions. Structure-guided disulfide engineering identifies a functional coupling between residue R1441 and switch II that directly modulates GTPase activity in both isolated ROC and full-length LRRK2. Disruption of this coupling phenocopies the disease-associated R1441H mutation. Together, these findings establish ROC as a dynamic conformational engine that drives a multistep intramolecular activation mechanism in LRRK2, providing mechanistic insight into how pathogenic mutations promote aberrant kinase activation.
- 12 July 2022
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 47 (12) , 1038-1047
Roc, the G-domain of the Parkinson’s disease-associated protein LRRK2
- 12 July 2022
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 47 (12) , 1038-1047
Roc, the G-domain of the Parkinson’s disease-associated protein LRRK2
- Open Access
- 29 June 2021
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 89, 63-72
A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease
- 29 June 2021
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 89, 63-72
Open AccessA new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease
- 1 June 2016
- Published by Elsevier in Journal of Structural Biology
- Vol. 194 (3) , 395-403
Crystal structure and functional analysis of isocitrate lyases from Magnaporthe oryzae and Fusarium graminearum
- 1 June 2016
- Published by Elsevier in Journal of Structural Biology
- Vol. 194 (3) , 395-403
Crystal structure and functional analysis of isocitrate lyases from Magnaporthe oryzae and Fusarium graminearum